OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Cardiology is 68. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Three different therapies to target PCSK9	644
Bariatric metabolic surgery more effective than GLP1R agonists in preventing congestive HF	576
Aggregation of big tau disrupts microtubules and causes diastolic dysfunction	476
Antibody treatment to deplete transthyretin amyloid deposits in the heart	435
Sacubitril–valsartan shows benefit in heart failure with ejection fraction of >40%	389
LIPC variant in combined hypocholesterolaemia	338
Intravascular imaging improves outcomes	295
Injectable and conductive cardiac patch	270
Basophils promote healing after MI	263
Travelling with heart failure: risk assessment and practical recommendations	249
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective	240
Screening for Helicobacter pylori infection in patients with cardiovascular and gastrointestinal disease	239
Accelerated reduction in global cardiovascular disease is essential to achieve the Sustainable Development Goals	233
Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications	229
Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults	219
Genetics and mechanisms of thoracic aortic disease	219
Abbreviating DAPT reduces the risk of bleeding	199
Alternative defibrillation strategies improve outcomes	198
Heterogeneity of the post-infarct epicardium	193
Defining iron deficiency in patients with heart failure	190
Detection of subclinical hypertrophic cardiomyopathy	190
Electron microscopy of cardiac 3D nanodynamics: form, function, future	189
Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization	179
Factor XI inhibitors in patients with cardiovascular disease and a high risk of bleeding: a cautionary tale	179
Hallmarks of cardiovascular ageing	165

PPAR control of metabolism and cardiovascular functions	158
Maternal cardiovascular disorders before and during pregnancy and offspring cardiovascular risk across the life course	158
Neuromodulation reduces inflammation in HFpEF	154
A fatty acid from mother’s milk drives cardiomyocyte maturation in newborn mice	151
Graded exercise therapy should not be recommended for patients with post-exertional malaise	148
Decongestion in heart failure: medical and device therapies	144
Extracellular matrix in vascular homeostasis and disease	144
Colchicine in acute coronary syndromes: the present and the possible future	137
Increased degradation of desmosomal proteins in ACM	134
Preparticipation screening reduces SCD in young athletes	134
CSDE1 regulates LDL receptor levels	131
Catheter ablation improves outcomes in patients with AF and end-stage HF	129
No benefit of apoA-I infusion after myocardial infarction	123
Identifying leukocyte phenotypes by scRNA-seq to predict cardiovascular risk	122
LDL-cholesterol lowering with obicetrapib	116
Targeting immune cell recruitment in atherosclerosis	114
The oral microbiome in the pathophysiology of cardiovascular disease	112
Genomic enhancers in cardiac development and disease	110
Reactive oxygen species in hypertension	109
Prevention of atherosclerosis from childhood	103
Increasing representation and diversity in cardiovascular clinical trial populations	103
Treatment of mild chronic hypertension in pregnancy reduces pre-eclampsia risk	102
Semaglutide is beneficial in patients with HFpEF and obesity	100
RNA interference lowers triglyceride levels	98
Modelling pre-eclampsia and its cardiovascular effects	94
Not a spectator sport: improving participation of Black patients in cardiovascular clinical trials	93
Reply to ‘Graded exercise therapy should not be recommended for patients with post-exertional malaise’	93
Donor macrophages influence rejection of transplanted hearts	88
Bempedoic acid prevents cardiovascular events in statin-intolerant patients	88
Unlocking excellence in health care: the power of inclusive and sensitive language in medicine	86
Cardiac sarcomere turnover by unidirectional replacement of proteins	86
Evidence does not support the reduction of added sugar intake from all food sources	82
Promising novel siRNA for the treatment of hypertension	82
BP management with a village-doctor-led strategy	81
Global epidemiology of heart failure	81
Single-cell profiles of CHD and CM	76
An epigenome editing approach induces durable silencing of Pcsk9	75
CV benefits of finerenone in T2DM and CKD	74
Computational modelling of cardiovascular pathophysiology to risk stratify commercial spaceflight	71
Author Correction: The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis	70
Novel factor XIa inhibitor reduces bleeding compared with apixaban in atrial fibrillation	69
Simvastatin protects against endothelial dysfunction via epigenetic mechanisms	69
The role of the molecular autopsy in sudden cardiac death in young individuals	68
Development of a miniature, bioresorbable, light-activated pacemaker	68